|
Active substance |
Teriflunomide |
|
Holder |
Sanofi |
|
Status |
closed |
|
Indication |
Relapsing Remitting Multiple Sclerosis in the pediatric population. |
|
Public documents |
|
| Approbation amendment | |
|
Last update |
24/05/2022 |
Aubagio®
Last updated on 10/09/2024